Charles Greenfield will be covering Angiotensin 2 during today's forum lecture. 

Objectives: 

Understand the role of RAAS dysregulation in the pathophysiology of distributive shock

Review current and impending clinical data supporting the utilization of angiotensin II in distributive shock management

Recognize patient phenotypes most likely to benefit from angiotensin II